PRIMO Post-Market Clinical Follow Up Study
NCT: NCT04843436 · COMPLETED
NCT IDNCT04843436
StatusCOMPLETED
Start Date2021-04-13
Completion2025-07-18
SponsorMMI (Medical Microinstruments, Inc.) (INDUSTRY)
First posted
Last updated
Brief Summary
Post Market Clinical Follow up Study aimed to collect clinical data on safety and efficacy of Robotically Assisted System called Symani to perform microsurgery techniques such as anastomosis, suturing and ligation for open surgery procedures on small anatomical structures such as blood vessels, lymphatic ducts and nerves.
Frequently Asked Questions
What is PRIMO Post-Market Clinical Follow Up Study?
PRIMO Post-Market Clinical Follow Up Study is a clinical trial registered under NCT04843436. Current status: COMPLETED.
What is the status of NCT04843436?
The current status of NCT04843436 (PRIMO Post-Market Clinical Follow Up Study) is: COMPLETED.
When did PRIMO Post-Market Clinical Follow Up Study start?
PRIMO Post-Market Clinical Follow Up Study started on 2021-04-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.